Stevanato Group SpA (STVN)
19.39
-0.47
(-2.37%)
USD |
NYSE |
Oct 07, 15:02
Stevanato Group Profit Margin (Quarterly) : 7.60% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.60% |
| March 31, 2026 | 10.24% |
| December 31, 2025 | 13.74% |
| September 30, 2025 | 11.90% |
| June 30, 2025 | 10.61% |
| March 31, 2025 | 10.33% |
| December 31, 2024 | 14.61% |
| September 30, 2024 | 10.80% |
| June 30, 2024 | 7.94% |
| March 31, 2024 | 7.97% |
| December 31, 2023 | 14.11% |
| September 30, 2023 | 13.96% |
| June 30, 2023 | 13.43% |
| Date | Value |
|---|---|
| March 31, 2023 | 11.88% |
| December 31, 2022 | 16.54% |
| September 30, 2022 | 14.80% |
| June 30, 2022 | 13.07% |
| March 31, 2022 | 13.09% |
| December 31, 2021 | 19.18% |
| September 30, 2021 | 8.69% |
| June 30, 2021 | 16.90% |
| March 31, 2021 | 18.96% |
| December 31, 2020 | |
| September 30, 2020 | 10.58% |
| June 30, 2020 | 12.79% |
| March 31, 2020 | 5.31% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 19.28% |
| Bio-Rad Laboratories, Inc. | 57.05% |
| Bruker Corp. | -6.07% |
| Danaher Corp. | 13.89% |
| Harvard Bioscience, Inc. | -12.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.12% |
| Return on Assets | 5.39% |
| Return on Invested Capital | 7.01% |
| Gross Profit Margin (Quarterly) | 27.86% |
| Operating Margin (Quarterly) | 16.17% |
| Return on Net Operating Assets | 6.06% |